Stay updated with breaking news from Term Milestone Expectations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
06.05.2024 - - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis expected in 2024 - - RaniPill HC to be ready for ...
- Cash runway extended into 2025 - - Announced strategic program prioritization, expansion of manufacturing and plans to streamline business operations - ...
10.05.2023 - - Announced partnership with Celltrion on development of RT-111, a RaniPill GO capsule containing a biosimilar for the monoclonal antibody ustekinumab - - Received preliminary feedback from FDA on RT-102 development plans; 505(b)(2) pathway for ...
Icosavax Provides Corporate Update and Anticipated Milestones for 2023 - read this article along with other careers information, tips and advice on BioSpace